Hybridan Small Cap Feast 06/10/22

Dish of the day Joiners: No joiners today. Leavers: No leavers today. What’s cooking in the IPO kitchen?** TECC Capital plc, to be renamed EDX Medical Group, intends to join the AQSE Growth Market. EDX operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development, provides Polymerase Chain Reaction (PCR) testing and genomic sequencing services, undertakes quality assurance and has established expertise in the design, development, validati

Morning Note – 6 October 2022

Haydale Graphene - FY2022 results in line with expectations

Haydale has reported FY results for the year ended June 2022. Revenue (£2.9m), adjusted LBITDA (£3.3m) and net debt (£0.2m) at the year-end were all in line with our forecasts and the July trading update. Cash has since been bolstered by the recent £5.15m net fundraise. Commercial progress remains encouraging, as Haydale continues to focus on products that can deliver commercial momentum most rapidly. We make no changes to operating forecasts and adjust for the recent open offer. Our target pric

Morning Note – 24 August 2022

Haydale Graphene - Further funding secured

HAYD has raised £5m (gross) through the placing and subscription for 250m shares at 2p, plus c.125m warrants also at 2p. There will be an Open Offer for up to 25.5m shares (and 12.75m warrants). This gives funding clarity to the business as it enters a phase of significant scale-up. HAYD is a key enabler of the nanomaterials revolution. Commercial momentum remains strong, notably in inks, Hi-Therm, Ceramyguard and US cutting tools. With breakeven revenue estimated at c.£10m, we can envisage HAYD

Morning Note – 19 July 2022

Hybridan Small Cap Feast 08/07/22

8 July 2022 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives

Morning Note – 7 June 2022

Hybridan Small Cap Feast 19/04/22

What’s cooking in the IPO kitchen? Lift Global Ventures plc to join AQSE Growth Market. The Company's investment strategy is to operate as an enterprise company seeking acquisition or investment opportunities within the financial media and technology industries. Within these broad industries, areas of focus may include: Financial news websites and other forms of “new media”, Investment research providers, Financial PR, IR, design and marketing agencies, Production studios and visual content prov

Machinations - finnCap Industrial Technology quarterly sector note

Company results surprisingly resilient in the face of multi-faceted challenges. The Industrial Technology Sector share prices have been badly affected over recent months, despite underlying company trading statements and recent annual results in March being mostly in line with expectations. The Ukraine invasion is the latest in a line of challenges that managements have had to overcome over the past two years. The greatest challenges for the sector and the wider economy have centred around the w

Hybridan Small Cap Feast 09/03/2022

Dish of the day Joiners: Invinity Energy Systems plc (AIM:IES), a leading global manufacturer of utility-grade energy storage has dual listed on the Aquis Stock Exchange. Leavers: No leavers today. What’s cooking in the IPO kitchen? New Energy One Acquisition Corporation Plc, intends to float on Main Market. NEOA is a special purpose acquisition company incorporated in the United Kingdom that has been established to focus on pursuing a Business Combination with targets that are positioned to par

Morning Note – 25 February 2022

Haydale Graphene - Enabler of a nanomaterials revolution

Graphene has many remarkable properties but, because it is relatively inert and unreactive, early pioneers have struggled to incorporate it into materials and products and extract anything like its promised benefits. HAYD has developed a process, HDPlas, which is highly successful in ‘functionalising’ Graphene. We believe HDPlas could be a major enabler of a future Graphene revolution, applicable to a huge range of end markets. The opportunity is wider than Graphene, as HDPlas can functionalise

Hybridan Small Cap Feast 12/02/22

Genflow Biosciences, a UK-based biotechnology company focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with advanced age intends to float on the Main Market (Standard). The Company will become the first longevity biotechnology firm to list in Europe. Genflow has raised £3.7m in an oversubscribed placing, conditional upon admission becoming effective. The flotation will value Genflow at approximately £23.4m. SuperSeed Capital Limited

50 Shades of Hydrogen - Hybridan Sector Review

Against the backdrop of the 26th UN Climate Change Conference of the Parties (COP26) we take a closer look at the rapidly developing technology and industries surrounding the evolution of the so-called hydrogen economy. Hydrogen is an energy vector or fuel that is capable of storing, transforming and transporting energy with zero emissions at the point of use. It can also be made by renewable energy sources. It is also the most abundant element in the universe accounting for some 75% of all matt